Recommended format for a Research Protocol
PART 1
Project
summary
Like the abstract of a research
paper, the project summary, should be no more than 300 words and at the most a
page long (font size 12, single spacing). Provided preferably on a separate
page, it should summarize all the central elements of the protocol, for example
the rationale, objectives, methods, populations, time frame, and expected
outcomes. It should stand on its own, and not refer the reader to points in the
project description.
General
information
- Protocol title, protocol identifying number (if any), and date.
- Name and address of the sponsor/funder.
- Name and title of the investigator(s) who is (are) responsible for conducting the research, and the address and telephone number(s) of the research site(s), including responsibilities of each.
- Name(s) and address(es) of the clinical laboratory(ies) and other medical and/or technical department(s) and/or institutions involved in the research
Rationale
& background information
The Rationale specifies the reasons
for conducting the research in light of current knowledge. It should include a
well documented statement of the need/problem that is the basis of the project,
the cause of this problem and its possible solutions. It is the equivalent to
the introduction in a research paper and it puts the proposal in context. It
should answer the question of why and what: why the research needs to be done
and what will be its relevance. The magnitude, frequency, affected geographical
areas, ethnic and gender considerations, etc of the problem should be followed by
a brief description of the most relevant studies published on the subject.
References
(of literature cited in preceding sections)
References can also be listed at the
end of Part 1.
Study
goals and objectives
Goals are broad statements of what
the proposal hopes to accomplish. They create a setting for the proposal.
Specific objectives are statements of the research question(s). Objectives
should be simple (not complex), specific (not vague), and stated in advance
(not after the research is done). After statement of the primary objective,
secondary objectives may be mentioned.
Study
Design
The scientific integrity of the
study and the credibility of the study data depend substantially on the study
design and methodology. The design of the study should include information on
the type of study, the research population or the sampling frame, and who can
take part (e.g. inclusion and exclusion criteria, withdrawal criteria etc.),
and the expected duration of the study
(The same study can be described in
several ways, and as complete a description of the study as possible should be
provided. For example, a study may be described as being a basic science
research, epidemiologic or social science research, it may also be described as
observational or interventional; if observational, it may be either descriptive
or analytic, if analytic it could either be cross-sectional or longitudinal
etc. If experimental, it may be described as a controlled or a non controlled
study.
Methodology
The methodology section is the most
important part of the protocol. It should include detailed information on the
interventions to be made, procedures to be used, measurements to be taken,
observations to be made, laboratory investigations to be done etc. If multiple
sites are engaged in a specified protocol, methodology should be standardized
and clearly defined.
Interventions should be described in detail, including a description of the drug/device/vaccine that is being tested. Interventions could also be in the realm of social sciences for example providing training or information to groups of individuals.
Procedures could be biomedical (collection of blood or sputum samples to develop a diagnostic test), or in the realm of social sciences (doing a questionnaire survey, carrying out a focus group discussion as part of formative research, observation of the participant's environment, etc.).
Standardized and/or documented procedures/techniques should be described and bibliographic references, if not provided earlier should be provided. Instruments which are to be used to collect information (questionnaires, FGD guides, observation recording form, case report forms etc.) must also be provided.
In the case of a randomized controlled trial additional information on the process of randomization and blinding, description of stopping rules for individuals, for part of the study or entire study, the procedures and conditions for breaking the codes etc. should also be described.
Interventions should be described in detail, including a description of the drug/device/vaccine that is being tested. Interventions could also be in the realm of social sciences for example providing training or information to groups of individuals.
Procedures could be biomedical (collection of blood or sputum samples to develop a diagnostic test), or in the realm of social sciences (doing a questionnaire survey, carrying out a focus group discussion as part of formative research, observation of the participant's environment, etc.).
Standardized and/or documented procedures/techniques should be described and bibliographic references, if not provided earlier should be provided. Instruments which are to be used to collect information (questionnaires, FGD guides, observation recording form, case report forms etc.) must also be provided.
In the case of a randomized controlled trial additional information on the process of randomization and blinding, description of stopping rules for individuals, for part of the study or entire study, the procedures and conditions for breaking the codes etc. should also be described.
A graphic outline of the study
design and procedures using a flow diagram must be provided. This should
include the timing of assessments.
Safety
Considerations
The safety of research participants
is foremost. Safety aspects of the research should always be kept in mind and
information provided in the protocol on how the safety of research participants
will be ensured. This can include procedures for recording and reporting
adverse events and their follow-up, for example. It is useful to remember that
even administering a research questionnaire can have adverse effects on
individuals.
Follow-Up
The research protocol must give a
clear indication of what follow up will be provided to the research
participants and for how long. This may include a follow u, especially for
adverse events, even after data collection for the research study is completed.
Data
Management and Statistical Analysis
The protocol should provide
information on how the data will be managed, including data handling and coding
for computer analysis, monitoring and verification. The statistical methods
proposed to be used for the analysis of data should be clearly outlined,
including reasons for the sample size selected, power of the study, level of
significance to be used, procedures for accounting for any missing or spurious
data etc. For projects involving qualitative approaches, specify in sufficient
detail how the data will be analysed.
Quality
Assurance
The protocol should describe the
quality control and quality assurance system for the conduct of the study,
including GCP, follow up by clinical monitors, DSMB, data management etc.
Expected
Outcomes of the Study
The protocol should indicate how the
study will contribute to advancement of knowledge, how the results will be
utilized, not only in publications but also how they will likely affect health
care, health systems, or health policies.
Dissemination
of Results and Publication Policy
The protocol should specify not only
dissemination of results in the scientific media, but also to the community
and/ or the participants, and consider dissemination to the policy makers where
relevant. Publication policy should be clearly discussed- for example who will
take the lead in publication and who will be acknowledged in publications, etc.
Duration
of the Project
The protocol should specify the time
that each phase of the project is likely to take, along with a detailed month
by month timeline for each activity to be undertaken.
Problems
Anticipated
This section should discuss the
difficulties that the investigators anticipate in successfully completing their
projects within the time frame stipulated and the funding requested. It should
also offer possible solutions to deal with these difficulties.
Project
Management
This section should describe the
role and responsibility of each member of the team
Ethics
The protocol should have a
description of ethical considerations relating to the study. This should not be
limited to providing information on how or from whom the ethics approval will
be taken, but this section should document the issues that are likely to raise
ethical concerns. It should also describe how the investigator(s) plan to
obtain informed consent from the research participants (the informed consent
process).
Informed
Consent Forms
The approved version of the protocol
must have copies of informed consent forms (ICF), both in English and the local
language in which they are going to be administered. However translations may
be carried out after the English language ICF(s) have been approved by the ERC.
If the research involves more than one group of individuals, for example
healthcare users and healthcare providers, a separate specifically tailored
informed consent form must be included for each group. This ensures that each
group of participants will get the information they need to make an informed
decision. For the same reason, each new intervention also requires a separate
informed consent form.
No comments:
Post a Comment